BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27729526)

  • 1. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line.
    Chu VT; Graf R; Wirtz T; Weber T; Favret J; Li X; Petsch K; Tran NT; Sieweke MH; Berek C; Kühn R; Rajewsky K
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12514-12519. PubMed ID: 27729526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system.
    Yin L; Maddison LA; Chen W
    Methods Cell Biol; 2016; 135():3-17. PubMed ID: 27443918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency and Inheritance of Targeted Mutagenesis in Maize Using CRISPR-Cas9.
    Zhu J; Song N; Sun S; Yang W; Zhao H; Song W; Lai J
    J Genet Genomics; 2016 Jan; 43(1):25-36. PubMed ID: 26842991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-Mediated Genome Engineering of Primary Human B Cells.
    Laoharawee K; Johnson MJ; Moriarity BS
    Methods Mol Biol; 2020; 2115():435-444. PubMed ID: 32006415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
    Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
    Li W; Ou G
    Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system.
    Zhou Y; Liu Y; Hussmann D; Brøgger P; Al-Saaidi RA; Tan S; Lin L; Petersen TS; Zhou GQ; Bross P; Aagaard L; Klein T; Rønn SG; Pedersen HD; Bolund L; Nielsen AL; Sørensen CB; Luo Y
    Cell Mol Life Sci; 2016 Jul; 73(13):2543-63. PubMed ID: 26755436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient CRISPR/Cas9-Mediated Mutagenesis in Primary Murine T Lymphocytes.
    Huang B; Johansen KH; Schwartzberg PL
    Curr Protoc Immunol; 2019 Feb; 124(1):e62. PubMed ID: 30312021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.
    Mollanoori H; Shahraki H; Rahmati Y; Teimourian S
    Hum Immunol; 2018 Dec; 79(12):876-882. PubMed ID: 30261221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting.
    Zhou J; Wang J; Shen B; Chen L; Su Y; Yang J; Zhang W; Tian X; Huang X
    FEBS J; 2014 Apr; 281(7):1717-25. PubMed ID: 24494965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient somatic and germline genome engineering of Bactrocera dorsalis by the CRISPR/Cas9 system.
    Zhao S; Xing Z; Liu Z; Liu Y; Liu X; Chen Z; Li J; Yan R
    Pest Manag Sci; 2019 Jul; 75(7):1921-1932. PubMed ID: 30565410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid generation of novel models of RAG1 deficiency by CRISPR/Cas9-induced mutagenesis in murine zygotes.
    Ott de Bruin L; Yang W; Capuder K; Lee YN; Antolini M; Meyers R; Gellert M; Musunuru K; Manis J; Notarangelo L
    Oncotarget; 2016 Mar; 7(11):12962-74. PubMed ID: 26887046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-Mediated In Vitro Mutagenesis in GC-Like B Cells.
    Chu VT; Graf R; Rajewsky K
    Methods Mol Biol; 2017; 1623():135-145. PubMed ID: 28589354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing.
    Park H; Shin J; Choi H; Cho B; Kim J
    Cells; 2020 Jun; 9(6):. PubMed ID: 32532133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-mediated targeted mutagenesis in upland cotton (Gossypium hirsutum L.).
    Janga MR; Campbell LM; Rathore KS
    Plant Mol Biol; 2017 Jul; 94(4-5):349-360. PubMed ID: 28258551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient CRISPR/Cas9-mediated targeted mutagenesis of multiple genes in Populus.
    Liu TT; Fan D; Ran LY; Jiang YZ; Liu R; Luo KM
    Yi Chuan; 2015 Oct; 37(10):1044-52. PubMed ID: 26496757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.